[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.125.253. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
July 26, 2006

Attacking Cervical Cancer

JAMA. 2006;296(4):384. doi:10.1001/jama.296.4.384-d

The US Food and Drug Administration has approved the first vaccine to protect women against cancer of the cervix, as well as a combination of drugs to improve survival in women with late-stage cervical cancer.

The vaccine, called Gardasil, is approved for use in girls and women from age 9 to 26 years. It is effective against 4 strains of the human papillomavirus. But because Gardasil does not protect against less common virus strains, routine Papanicolaou tests will continue to be important for detecting precancerous changes in the cervix.

First Page Preview View Large
First page PDF preview
First page PDF preview
×